Compound(7524-52-9)Formula: C12H15ClN2O2 received a lot of attention, and I have introduced some compounds in other articles, similar to this compound(H-Trp-OMe.HCl), if you are interested, you can check out my other related articles.
In general, if the atoms that make up the ring contain heteroatoms, such rings become heterocycles, and organic compounds containing heterocycles are called heterocyclic compounds. An article called Synthesis, molecular docking and biological evaluation of some new benzotriazines, published in 2019, which mentions a compound: 7524-52-9, Name is H-Trp-OMe.HCl, Molecular C12H15ClN2O2, Formula: C12H15ClN2O2.
Me 2-(4-oxobenzotriazin-3(4H)-yl)alkanoates I [X = CH2, CH2CH2, CH(i-Pr); X1 = MeO] proved to be important intermediates for the preparation of some biol. interesting compounds containing the benzotriazinone ring system. The above compounds were prepared by direct diazotization of Me anthranilate followed by addition of amino acid esters hydrochloride in a one-pot strategy. An equivocal synthesis of compound I (X = CH2; X1 = MeO) was achieved by alkylation of benzotriazin-4(3H)-one with Me chloroacetate. A series of N-alkyl-2-(4-oxobenzotriazin-3(4H)-yl) alkanamides I (X = CH2, CH2CH2; X1 = NR1R2; R1 = i-Pr, n-Bu, t-Bu, cyclohexyl, etc., R2 = H; R1R2N = 1-piperidinyl, 4-morpholinyl) and Me 2-(2-(4-oxobenzotriazin-3(4H)-yl)alkanamido)alkanoates (dipeptides) I [X = CH2, CH2CH2; X1 = NHR3; R3 = MeO2CCH2, MeO2CCH(i-Bu), MeO2C(CH2)3, MeO2CCH(indol-3-ylmethyl)] were prepared via azide coupling from compounds I (X = CH2, CH2CH2; X1 = MeO). Esters I (X = CH2, CH2CH2; X1 = MeO) were converted into the corresponding hydrazides followed by condensation with aldehydes, such as 4-methoxybenzaldehyde, 4-dimethylaminobenzaldehyde and arabinose, to afford the corresponding hydrazone derivatives. All the synthesized compounds were subjected to the mol. docking using MOE 2008-10 software as agonists for E. coli Fab-H receptor and Vitamin D receptor for antibacterial and anticancer evaluation, resp. The most pronounced strong binding affinity towards the target E. coli Fab-H receptor was shown by the parent benzotriazin-4(3H)-one and compounds I [X = CH2, X1 = i-PrNH; X = CH2CH2, X1 = MeO2CCH2, MeO2C(CH2)3; X = CH2, X1 = 4-MeOC6H4CH:NN, 4-Me2NC6H4CH:NN; X = CH2CH2, X1 = 4-Me2NC6H4CH:NN]. On the other hand, the most pronounced strong binding affinity towards the target Vitamin D receptor were benzotriazin-4(3H)-one and compounds I [X = CH2, X1 = MeO2C(CH2)3; X = CH2CH2, X1 = MeO2CCH(indol-3-ylmethyl); X = CH2, X1 = 4-MeOC6H4CH:NN]. The in-vitro antibacterial activity of highest binding affinity docked compounds were tested against E. coli, Staphylococcus aureus and Salmonella spp. All the tested compounds gave effective pos. results against E. coli with inhibitory zone of about 1.1 cm, while were inactive against Staphylococcus aureus and Salmonella spp. The in-vitro cytotoxic activity of the highest binding affinity docked compounds were tested against human liver carcinoma cell line (HepG2) cancer cell lines. Many compounds showed potent cytotoxic activity with low IC50 values, especially benzotriazin-4(3H)-one (6.525μM) and I (X = CH2; X1 = 4-MeOC6H4CH:NN) (10.97μM) compared to standard drug doxorubicin (5.8μM).
Compound(7524-52-9)Formula: C12H15ClN2O2 received a lot of attention, and I have introduced some compounds in other articles, similar to this compound(H-Trp-OMe.HCl), if you are interested, you can check out my other related articles.
Reference:
1,3-Benzodioxole – Wikipedia,
Dioxole | C3H4O2 – PubChem